Type 2 diabetes mellitus, cognitive impairment and dementia

被引:414
作者
Stewart, R [1 ]
Liolitsa, D [1 ]
机构
[1] Inst Psychiat, Sect Old Age Psychiat, London SE5 8AF, England
基金
英国惠康基金;
关键词
advanced glycation end products; Alzheimer's disease; apolipoprotein E; cerebrovascular disease; cognitive decline; cognitive impairment; dementia; dyslipidaemia; hyperglycaemia; hypertension; hypoglycaemia; insulin resistance; mixed dementia; post-stroke dementia; Type 2 diabetes mellitus; vascular dementia;
D O I
10.1046/j.1464-5491.1999.00027.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims We set out to examine the evidence for an association between cognitive impairment or dementia and the presence of Type 2 diabetes mellitus (DM). We also sought evidence of potential mechanisms for such an association. Methods A literature search of three databases was performed and the reference lists of the papers so identified were examined, using English language papers only. Results We found evidence of cross-sectional and prospective associations between Type 2 DM and cognitive impairment, probably both for memory and executive function. There is also evidence for an elevated risk of both vascular dementia and Alzheimer's disease in Type 2 DM albeit with strong interaction of other factors such as hypertension, dyslipidaemia and apolipoprotein E phenotype. Both vascular and non-vascular factors are likely to play a role in dementia in diabetes. Conclusions Current classification structures for dementia may not be adequate in diabetes, where mixed pathogenesis is likely. Further research into the mechanisms of cognitive impairment in Type 2 DM may allow us to challenge the concept of dementia, at least in these patients, as an irremediable disease.
引用
收藏
页码:93 / 112
页数:20
相关论文
共 146 条
[1]   A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling - Evidence from transfection studies [J].
Almind, K ;
Inoue, G ;
Pedersen, O ;
Kahn, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2569-2575
[2]  
Amato L, 1996, DIABETES METAB, V22, P314
[3]   DIABETES AND DEMENTIA - A CAUSAL ASSOCIATION [J].
AMIEL, SA .
DIABETIC MEDICINE, 1994, 11 (05) :430-431
[4]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[5]   Diabetes and cognitive function: Preliminary studies [J].
Assisi, A ;
Alimenti, M ;
Maceli, F ;
DiPietro, S ;
Lalloni, G ;
Montera, P .
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1996, :229-232
[6]   NEUROPSYCHOLOGICAL FUNCTION IN OLDER SUBJECTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
ATIEA, JA ;
MOSES, JL ;
SINCLAIR, AJ .
DIABETIC MEDICINE, 1995, 12 (08) :679-685
[7]   The influence of depressive symptomatology on episodic memory functioning among clinically nondepressed older adults [J].
Backman, L ;
Hill, RD ;
Forsell, Y .
JOURNAL OF ABNORMAL PSYCHOLOGY, 1996, 105 (01) :97-105
[8]   CEREBRAL FUNCTION IN DIABETES-MELLITUS [J].
BIESSELS, GJ ;
KAPPELLE, AC ;
BRAVENBOER, B ;
ERKELENS, DW ;
GISPEN, WH .
DIABETOLOGIA, 1994, 37 (07) :643-650
[9]   Prevalence of diabetes and effect on quality of life in older French living in the community: The PAQUID epidemiological survey [J].
BourdelMarchasson, I ;
Dubroca, B ;
Manciet, G ;
Decamps, A ;
Emeriau, JP ;
Dartigues, JF .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (03) :295-301
[10]   DIFFERENTIAL-EFFECTS OF INSULIN ON CHOLINE-ACETYLTRANSFERASE AND GLUTAMIC-ACID DECARBOXYLASE ACTIVITIES IN NEURON-RICH STRIATAL CULTURES [J].
BRASS, BJ ;
NONNER, D ;
BARRETT, JN .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (02) :415-424